Evidence map›Paper›PMID 7724596›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1995

Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration.

T Li, W K Franson, J W Gordon, E L Berson, T P Dryja

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 130 citations in OpenAlex.

  1. Review
  2. Aggregation of the Constitutively Active K296E Rhodopsin Mutant Contributes to Retinal Degeneration.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  3. Arrestin Facilitates Rhodopsin DephosphorylationThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  4. Review
  5. Arrestins: Critical Players in Trafficking of Many GPCRs.Progress in molecular biology and translational science · 2015
    Review
  6. Article
  7. Gene augmentation for adRP mutations in RHO.Cold Spring Harbor perspectives in medicine · 2014
    Review
  8. Constitutively active rhodopsin and retinal disease.Advances in pharmacology (San Diego, Calif.) · 2014
    Review
  9. Visual arrestin interaction with clathrin adaptor AP-2 regulates photoreceptor survival in the vertebrate retina.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Severe retinal degeneration caused by a novel rhodopsin mutation.Investigative ophthalmology & visual science · 2010
    Article
  20. Diversity in arrestin function.Cellular and molecular life sciences : CMLS · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

T LiBerman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.
W K Franson
J W Gordon
E L Berson
T P Dryja
Massachusetts Eye and Ear Infirmary · US

Funding

MODELS OF PHOTORECEPTOR DISEASER01EY010309 · NEI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI SANDBERG, MICHAEL A · 1994 to 2008
$2.6M
Therapies for Photoreceptor DegenerationR01EY010581 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI SANDBERG, MICHAEL A · 2001 to 2008
$1.4M
SOMATIC GENE THERAPY IN MODELS OF RETINAL DEGENERATIONR29EY010581 · NEI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI LI, TIANSEN · 1994 to 1998
–
NEI NIH HHS EY10309NEI NIH HHS EY10581
6 · The paper itself

Abstract

The missense mutation Lys-296-->Glu (K296E) in the rhodopsin gene produces an opsin with no chromophore binding site and therefore is not activated by light. Nevertheless, the mutant opsin constitutively activates transducin in vitro and causes photoreceptor degeneration in vivo, possibly by continuously activating the phototransduction cascade, analogous to constant exposure to environmental light. We studied the K296E mutation in eight lines of transgenic mice. Each line developed photoreceptor degeneration with the rate of degeneration increasing monotonically as the ratio of mutant:wild-type opsin mRNA increased. At no time in the course of degeneration was there endogenous light adaptation in the retina as measured by the electroretinogram. The mutant opsin was found to be invariably phosphorylated and stably bound to arrestin. Light-independent activation of transducin was demonstrated only after the removal of arrestin and dephosphorylation of K296E opsin. Thus, K296E opsin in vivo does not activate the phototransduction cascade because it is shut off by photoreceptor inactivation mechanisms. Our data show that the K296E mutation does not cause photoreceptor degeneration by continuous activation of phototransduction.

Indexed as

AnimalsAntigensArrestinBase SequenceDarknessElectroretinographyEnzyme ActivationEye ProteinsImmunohistochemistryMiceMice, TransgenicMolecular Sequence DataMutationPhosphorylationPhotoreceptor CellsProtein BindingAntigensArrestinEye ProteinsRod OpsinsTransducin

Identifiers

PMID7724596
PMCPMC42205
OpenAlexW2094612773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.